|
Market Closed -
Deutsche Boerse AG
13:11:55 2026-09-21 EDT
|
5-day change | 1st Jan Change | ||
| 49.04 EUR | +1.87% |
|
-0.67% | +32.59% |
| 09-21 | Bayer Sells Cancer Drug to Gruenenthal for Up to $431 Million | DJ |
| 09-20 | Grünenthal GmbH agreed to acquire Stivarga from Bayer Aktiengesellschaft for approximately ?380 million. | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Bayer AG(BAYN)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Bayer AG(BAYN)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Bayer AG(BAYN)
EBIT
Dividend / Share (DPS)
Data source:
Bayer AG(BAYN)
Cash or Net Debt
- Stock Market
- Stocks
- BAYN Stock
- BAYN Stock
- Consensus Bayer AG
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
